Ofatumumab monotherapy in fludarabine-refractory chronic lymphocytic leukemia: final results from a pivotal study. Article uri icon

Overview

publication date

  • March 13, 2015

Research

keywords

  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • Drug Resistance, Neoplasm
  • Leukemia, Lymphocytic, Chronic, B-Cell

Identity

PubMed Central ID

  • PMC5004432

Scopus Document Identifier

  • 84938603407

Digital Object Identifier (DOI)

  • 10.3324/haematol.2014.121459

PubMed ID

  • 25769539

Additional Document Info

volume

  • 100

issue

  • 8